A retrospective study to evaluate the efficacy and safety of combination of Bendamustine+ Rituximab in patients with relapsed or refractory Diffuse-large-B-cell-lymphoma.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2015
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 29 Nov 2015 New trial record